KOP Therapeutics Corp. — Form D

KOP Therapeutics Corp. of VANCOUVER, A1, a company, filed a Form D exempt-offering notice with the SEC on 2019-11-15. The offering totals $115K, of which $115K was reported sold. Industry: Biotechnology.

Offering

Filed: 2019-11-15
Form: D
Accession: 0001683168-19-003656
Industry: Biotechnology
Exemptions: 06c
Total offering: $115K
Amount sold: $115K
Investors: 3
Date of first sale: 2019-10-22
Security types: equity
Revenue range: No Revenues
SEC file number: 021-353470

Issuer

Name: KOP Therapeutics Corp.
CIK: 0001793824
Entity type: Corporation
Jurisdiction: BRITISH COLUMBIA, CANADA
Incorporated: 2018
Address: SUITE 404 - 815 HORNBY STREET, VANCOUVER, A1, V6Z 2E6
Phone: 6047718332

Officers, directors & promoters (6)

Name	Role	Location
Mark Richard Redcliffe	Director	VANCOUVER, A1
Mark Richard Redcliffe	Executive Officer	VANCOUVER, A1
Tibor Fancis Gajdics	Director	VANCOUVER, A1
Tibor Fancis Gajdics	Executive Officer	VANCOUVER, A1
Ian Hollis Mann	Director	VANCOUVER, A1
Marco Andres Strub	Director	VANCOUVER, A1

Other filings by this issuer (2)

Filed	Form	Offering	Sold
2020-01-31	D/A	$114K	$114K
2019-12-19	D/A	$114K	$114K

More